Trial Profile
A retrospective study to evaluate the effect of Rituximab on growth (in terms of height) and weight in children having steroid-dependent nephrotic syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- 29 Nov 2015 New trial record